Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of Tumor Imaging With Multispectral Optoacoustic Tomography
Sponsor: Memorial Sloan Kettering Cancer Center
Summary
Participants in this study will have Multispectral Optoacoustic Tomography/MSOT imaging of both breasts immediately before their ultrasound-guided breast biopsy procedure begins. After the MSO imaging is completed, participation in the study will end.
Official title: A Feasibility Study of Multispectral Optoacoustic Tomography (MSOT) Imaging in Patients With Tumors
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
12
Start Date
2022-07-27
Completion Date
2026-07-27
Last Updated
2026-02-19
Healthy Volunteers
Yes
Conditions
Interventions
Multispectral Optoacoustic Tomography Imaging
Each participants will undergo MSOT imaging of the suspicious breast tumor detected with ultrasound imaging and any additional lesion present in either breast before undergoing ultrasound-guided breast biopsy as the standard of care. Melanoma participants with pathologically confirmed ITM will undergo MSOT imaging following physical exam and biopsy. Melanoma patients receiving immunotherapy will undergo MSOT imaging prior to and following immunotherapy.
Locations (4)
Memorial Sloan Kettering Bergen (Consent only )
Montvale, New Jersey, United States
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent only)
Commack, New York, United States
Memorial Sloan - Kettering Cancer Center
New York, New York, United States
Helmholtz Institute (Data Analysis Only)
Munich, Germany